Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes

Obesity

Volumn 16, Issue 6, 2008, Pages 1208-1218

  Cao, Heping ^a   Urban Jr , Joseph F ^a   Anderson, Richard A ^a  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTIDIABETIC AGENT; INSULIN; MESSENGER RNA; NUCLEAR PROTEIN; RNA BINDING PROTEIN; TRISTETRAPROLIN; VASCULOTROPIN A; ZFP36 PROTEIN, MOUSE; ZFP36L1 PROTEIN, MOUSE; ZFP36L3 PROTEIN, MOUSE;

ADIPOCYTE; ANIMAL; ARTICLE; CELL LINE; CELL STRAIN 3T3; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; MACROPHAGE; METABOLISM; MOUSE; OBESITY; PATHOLOGY; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; MACROPHAGES; MICE; NUCLEAR PROTEINS; OBESITY; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRISTETRAPROLIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42049085250     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.65     Document Type: Article

References (59)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867.
2. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006;83:461S-465S.
3. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
4. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783.
5. Lai WS, Stumpo DJ, Blackshear PJ. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem 1990;265:16556-16563.
6. Lin NY, Lin CT, Chen YL, Chang CJ. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes. FEBS J 2007;274:867-878.
7. Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 2007;459:214-222.
8. Bouchard L, Tchernof A, Deshaies Y et al. ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg 2007;17:372-382.
9. Bouchard L, Vohl MC, Deshaies Y et al. Visceral adipose tissue zinc finger protein 36 mRNA levels are correlated with insulin, insulin resistance index, and adiponectinemia in women. Eur J Endocrinol 2007;157:451-457.
10. Blackshear PJ. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans 2002;30:945-952.
11. Blackshear PJ, Phillips RS, Ghosh S et al. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod 2005;73:297-307.
12. Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol 2004;11:257-264.
13. Taylor GA, Carballo E, Lee DM et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996;4:445-454.
14. Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci USA 2004;101:2011-2016.
15. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998;281:1001-1005.
16. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 2000;95:1891-1899.
17. Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol 2005;174:953-961.
18. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. Novel mRNA targets for Tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 2006;26:9196-9208.
19. Stumpo DJ, Byrd NA, Phillips RS et al. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the tristetraprolin family. Mol Cell Biol 2004;24:6445-6455.
20. Bell SE, Sanchez MJ, Spasic-Boskovic O et al. The RNA binding protein Zfp36l1 is required for normal vascularisation and post- transcriptionally regulates VEGF expression. Dev Dyn 2006;235:3144-3155.
21. Ramos SB, Stumpo DJ, Kennington EA et al. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development. Development 2004;131:4883-4893.
22. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 2001;276:34167-34174.
23. Welsh GI, Griffiths MR, Webster KJ, Page MJ, Tavare JM. Proteome analysis of adipogenesis. Proteomics 2004;4:1042-1051.
24. Jarvill-Taylor KJ, Anderson RA, Graves DJ. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 2001;20:327-336.
25. Cao H, Tuttle JS, Blackshear PJ. Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein. J Biol Chem 2004;279:21489-21499.
26. Dawson HD, Beshah E, Nishi S et al. Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum. Infect Immun 2005;73:1116-1128.
27. Cao H, Dzineku F, Blackshear PJ. Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases. Arch Biochem Biophys 2003;412:106-120.
28. Cao H, Lin R, Ghash S, Anderson RA, Urban JF Jr. Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli. Biotechnol Prog 2008;24:326-333.
29. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537-1545.
30. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-2355.
31. Cao H. Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications. Biochemistry 2004;43:13724-13738.
32. Lai WS, Carballo E, Strum JR et al. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999;19:4311-4323.
33. Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pages G. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol Biol Cell 2007;18:4648-4658.
34. Carballo E, Cao H, Lai WS et al. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem 2001;276:42580-42587.
35. Cao H, Deterding LJ, Venable JD et al. Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis. Biochem J 2006;394:285-297.
36. Cao H, Deterding LJ, Blackshear PJ. Phosphorylation site analysis of the anti-inflammatory and mRNA destabilizing protein tristetraprolin. Expert Rev Proteomics. 2007;4:711-726.
37. DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem 1990;265:19185-19191.
38. Varnum BC, Lim RW, Kujubu DA et al. Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol Cell Biol 1989;9:3580-3583.
39. Sauer I, Schaljo B, Vogl C et al. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 2006;107:4790-4797.
40. Cousins RJ, Blanchard RK, Popp MP et al. A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc Natl Acad Sci USA 2003;100:6952-6957.
41. Cao H, Kelly MA, Kari F et al. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm (Lond) 2007;4:1.
42. Taddeo B, Zhang W, Roizman B. The U(L)41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins. Proc Natl Acad Sci USA 2006;103:2827-2832.
43. Wang P, Keijer J, Bunschoten A, Bouwman F, Renes J, Mariman E. Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing. Diabetologia 2006;49:2453-2462.
44. Corps AN, Brown KD. Insulin and insulin-like growth factor I stimulate expression of the primary response gene cMG1/TIS11b by a wortmannin-sensitive pathway in RIE-1 cells. FEBS Lett 1995;368:160-164.
45. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
46. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967-974.
47. Nishimura S, Manabe I, Nagasaki M et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells and blood vessels. Diabetes 2007;56:1517-1526.
48. Rodriguez SK, Guo W, Liu L et al. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 2006;118:1635-1644.
49. Miyazawa-Hoshimoto S, Takahashi K, Bujo H et al. Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am J Physiol Endocrinol Metab 2005;288:E1128-E1136.
50. Emoto M, Anno T, Sato Y et al. Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes. Diabetes 2001;50:1166-1170.
51. Mick GJ, Wang X, McCormick K. White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 2002;143:948-953.
52. Fain JN, Madan AK. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism 2005;54:220-226.
53. Poulaki V, Qin W, Joussen AM et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest 2002;109:805-815.
54. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, Van OE. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 2000;275:21695-21702.
55. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van OE. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 2002;277:27975-27981.
56. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 2003;278:47585-47593.
57. Ciais D, Cherradi N, Bailly S et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 2004;23:8673-8680.
58. Carrick DM, Blackshear PJ. Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys 2007;462:278-285.
59. Cao H, Urban JF Jr, Anderson RA. Cinnamon polyphenol extract effects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J Nutr, in press.